Starbucks China responded to the new Chief Growth Officer: promoting the sustainable development of Starbucks brand in China. Recently, some media reported that the management of Starbucks China continued to adjust and hired CGO to manage the growth from digital marketing companies. In response to the above information, Sina Technology verified Starbucks, and the official response said: China is Starbucks' largest international market and an important engine for the company's future growth. In November, Starbucks China established the Chief Growth Officer (CGO) organization and appointed Tony Yang as the company's Chief Growth Officer (CGO). The establishment of CGO organization will continue to strengthen Starbucks' coffee leadership, accelerate the product innovation with coffee as the core, better refresh customers' Starbucks experience at various contacts through integrated marketing strategies, and promote the sustainable development of Starbucks brand in China. (Sina Technology)Sony group's share price hit a record high in intraday trading.Musk praised Tesla China. According to the data, Tesla sold 21,900 vehicles in China last week (12.2-12.8), which was the second best week of Tesla in 2024 so far. The excellent sales performance in China market was highly recognized by Tesla CEO Musk, who praised "the excellent work of Tesla China" online on social media.
The semiconductor concept oscillated higher and Broadcom integrated daily limit, and the semiconductor concept oscillated higher and Broadcom integrated daily limit. Hengxuan Technology, Purran, Shanghai Beiling, Tailingwei and Dongxin shares rose more than 5%.The kitchen & bathroom appliances sector rose to 3 boards of Shuaifeng in the short term, and the kitchen & bathroom appliances sector rose to 3 boards of Shuaifeng, followed by Martians, Yitian Intelligent, Op Technology, Vantage and Wanhe Electric.AI glasses concept stocks continued to rise, with Zhongke Lanxun, Hengxuan Technology and Mingyue Lens rising more than 12%, while Tianjian, Xingxing Technology, Yiyuan Communication, Yitong Communication and Zhuoyi Technology had previous daily limit.
Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.South Korean banks' net household loans increased by 1.9 trillion won in October.South Korean banks' net household loans increased by 1.9 trillion won in October.